Today’s top gainers include the company Quest Diagnostics Inc. (NYSE:DGX) which is in the industry Medical Laboratories & Research, gaining -0.10% today. In the last week its performance is 0.57%, and 14.19% for the past quarter. Currently, Quest Diagnostics Inc., DGX has a target price of 82.5, so today’s gain of -0.10% is a significant step towards its target price. The GAP today is therefore 0.23%.
Quest Diagnostics Inc. (NYSE:DGX), has a market cap of 12012, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 99.70%.
At the current price of 85.71, it has a dividend yield of 1.86%, and its target price is 82.5. This is with a profit margin of 11.00%, and total debt/equity of 0.85. Quest Diagnostics Inc. (NYSE:DGX) has a P/E of 15.01, as well as a forward P/E of 15.74.
With a current EPS of 5.72, and a forecasted EPS growth for next year at 6.72%,Quest Diagnostics Inc. (NYSE:DGX) has had a EPS growth for the past five years at 4.10%. For the next five years EPS growth is projected to be 7.82%.
Performance for the year is 17.79%. Since its IPO date on 12/26/1996, the total performance to date is 22.56%.
Volume today for Quest Diagnostics Inc. (NYSE:DGX), is 309037, while its average volume is 1206. Whilst the total gain today was -0.10%, it did have a day high of -1.31%.
Volatility for this week has been at 1.18%, and 1.20% for the month. The 52-week low for Quest Diagnostics Inc., DGX has been 45.89%, while the 52-week-high has reached -1.31%.
Looking at its return of investments, which is 12.30%, and its return on assets is 8.20%. Quest Diagnostics Inc. (NYSE:DGX) has an operating margin of 20.70%. With a sales growth of -1.00% quarter over quarter. Bearing in mind that Quest Diagnostics Inc., DGX is in the sector Healthcare, its long-term debt/equity is 0.85, and has a current ratio of 1.4 and 1.3 for quick ratio.
So what is the value of Quest Diagnostics Inc.? Well its PEG is 1.92, and the P/S is 1.6, along with a P/B of 2.65. Meanwhile it has a p/cash of 42.45.